Cargando…

Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease”

Detalles Bibliográficos
Autores principales: Phillips-Farfán, Bryan, Carvajal, Karla, Medina-Torres, Edgar Alejandro, Espinosa-Padilla, Sara Elva, Fabrias, Gemma, Camacho, Luz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124652/
https://www.ncbi.nlm.nih.gov/pubmed/27965522
http://dx.doi.org/10.1155/2016/7267956
_version_ 1782469874779422720
author Phillips-Farfán, Bryan
Carvajal, Karla
Medina-Torres, Edgar Alejandro
Espinosa-Padilla, Sara Elva
Fabrias, Gemma
Camacho, Luz
author_facet Phillips-Farfán, Bryan
Carvajal, Karla
Medina-Torres, Edgar Alejandro
Espinosa-Padilla, Sara Elva
Fabrias, Gemma
Camacho, Luz
author_sort Phillips-Farfán, Bryan
collection PubMed
description
format Online
Article
Text
id pubmed-5124652
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-51246522016-12-13 Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease” Phillips-Farfán, Bryan Carvajal, Karla Medina-Torres, Edgar Alejandro Espinosa-Padilla, Sara Elva Fabrias, Gemma Camacho, Luz Mediators Inflamm Corrigendum Hindawi Publishing Corporation 2016 2016-11-14 /pmc/articles/PMC5124652/ /pubmed/27965522 http://dx.doi.org/10.1155/2016/7267956 Text en Copyright © 2016 Bryan Phillips-Farfán et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Phillips-Farfán, Bryan
Carvajal, Karla
Medina-Torres, Edgar Alejandro
Espinosa-Padilla, Sara Elva
Fabrias, Gemma
Camacho, Luz
Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease”
title Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease”
title_full Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease”
title_fullStr Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease”
title_full_unstemmed Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease”
title_short Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease”
title_sort corrigendum to “sphingolipids as mediators in the crosstalk between microbiota and intestinal cells: implications for inflammatory bowel disease”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124652/
https://www.ncbi.nlm.nih.gov/pubmed/27965522
http://dx.doi.org/10.1155/2016/7267956
work_keys_str_mv AT phillipsfarfanbryan corrigendumtosphingolipidsasmediatorsinthecrosstalkbetweenmicrobiotaandintestinalcellsimplicationsforinflammatoryboweldisease
AT carvajalkarla corrigendumtosphingolipidsasmediatorsinthecrosstalkbetweenmicrobiotaandintestinalcellsimplicationsforinflammatoryboweldisease
AT medinatorresedgaralejandro corrigendumtosphingolipidsasmediatorsinthecrosstalkbetweenmicrobiotaandintestinalcellsimplicationsforinflammatoryboweldisease
AT espinosapadillasaraelva corrigendumtosphingolipidsasmediatorsinthecrosstalkbetweenmicrobiotaandintestinalcellsimplicationsforinflammatoryboweldisease
AT fabriasgemma corrigendumtosphingolipidsasmediatorsinthecrosstalkbetweenmicrobiotaandintestinalcellsimplicationsforinflammatoryboweldisease
AT camacholuz corrigendumtosphingolipidsasmediatorsinthecrosstalkbetweenmicrobiotaandintestinalcellsimplicationsforinflammatoryboweldisease